Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for IQVIA Holdings Inc. (IQV : NYSE)
 
 • Company Description   
IQVIA Holdings Inc. provides advanced analytics, technology solutions and contract research services to the life sciences industry. The company was formed through the merger of IMS Health (RX) and Quintiles. The company is focused on helping healthcare clients to better serve patients by bringing in updated and innovative ideas in the process of clinical development and commercialization, speed innovation and accelerate improvements. I

Number of Employees: 88,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $148.99 Daily Weekly Monthly
20 Day Moving Average: 1,890,447 shares
Shares Outstanding: 173.00 (millions)
Market Capitalization: $25,775.27 (millions)
Beta: 1.34
52 Week High: $252.88
52 Week Low: $135.97
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 2.36% -3.00%
12 Week -22.98% -16.79%
Year To Date -24.18% -21.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2400 ELLIS ROAD
-
DURHAM,NC 27703
USA
ph: 919-998-2000
fax: -
ir@iqvia.com http://www.iqvia.com
 
 • General Corporate Information   
Officers
Ari Bousbib - Chief Executive Officer;Chairman;Director
Ronald E. Bruehlman - Executive Vice President and Chief Financial Offic
Keriann Cherofsky - Senior Vice President; Chief Accounting Officer an
Carol J. Burt - Director
John P. Connaughton - Director

Peer Information
IQVIA Holdings Inc. (ABMD)
IQVIA Holdings Inc. (DMDS)
IQVIA Holdings Inc. (CPWY.)
IQVIA Holdings Inc. (EQUR)
IQVIA Holdings Inc. (ECIA)
IQVIA Holdings Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 46266C105
SIC: 8731
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 07/28/25
Share - Related Items
Shares Outstanding: 173.00
Most Recent Split Date: (:1)
Beta: 1.34
Market Capitalization: $25,775.27 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $2.55 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $10.86 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 10.00 Change In Payout Ratio: 0.00
Estmated Long-Term EPS Growth Rate: 8.54% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/28/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 13.72
Trailing 12 Months: 14.44
PEG Ratio: 1.61
Price Ratios
Price/Book: 4.39
Price/Cash Flow: 8.97
Price / Sales: 1.66
EPS Growth
vs. Year Ago Period: 3.04%
vs. Previous Quarter: -18.28%
Sales Growth
vs. Year Ago Period: 2.46%
vs. Previous Quarter: -3.26%
ROE
03/31/25 - 29.16
12/31/24 - 28.81
09/30/24 - 28.17
ROA
03/31/25 - 6.96
12/31/24 - 7.02
09/30/24 - 6.89
Current Ratio
03/31/25 - 0.82
12/31/24 - 0.84
09/30/24 - 0.81
Quick Ratio
03/31/25 - 0.82
12/31/24 - 0.84
09/30/24 - 0.81
Operating Margin
03/31/25 - 12.10
12/31/24 - 12.20
09/30/24 - 12.02
Net Margin
03/31/25 - 8.61
12/31/24 - 8.91
09/30/24 - 9.17
Pre-Tax Margin
03/31/25 - 10.66
12/31/24 - 10.83
09/30/24 - 9.78
Book Value
03/31/25 - 33.94
12/31/24 - 33.43
09/30/24 - 38.39
Inventory Turnover
03/31/25 - -
12/31/24 - -
09/30/24 - -
Debt-to-Equity
03/31/25 - 2.19
12/31/24 - 2.12
09/30/24 - 1.76
Debt-to-Capital
03/31/25 - 68.65
12/31/24 - 67.91
09/30/24 - 63.83
 

Powered by Zacks Investment Research ©